The interplay between neuroinflammatory and proteostatic biomarkers and NfL levels highlights the multifactorial nature of neurofilament release, positioning NfL as a downstream integrator of diverse pathological processes in ALS (Alshehri et al., 2024). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.